Oxytocin administration in High Intensity Focused Ultrasound (HIFU) treatment of myomata - utility oxytocin during HIFU treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00014794

Enrollment

151

Registered

2018-06-05

Start date

2017-05-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D25

Interventions

Group 1: 51 patients during HIFU treatment were performed oxytocin administration 40 units with 0,9% NACL solution. Group 2: 105 patients with uterus fibroids were performed HIFU treatment without med

Eligibility

Sex/Gender

Female

Age

22 Years to 43 Years

Inclusion criteria

Inclusion criteria: Symptomatic fibroids, size <13 cm

Exclusion criteria

Exclusion criteria: Fibroids size >13cm, non-symptomatic

Design outcomes

Primary

Measure	Time frame
Non-perfused volume measured after treatment, volume of fibroids measured 6 month after procedure	—

Countries

Poland

Contacts

Public ContactTomasz Lozinski

Szpital Pro-Famiia

tomasz.lozinski@pro-familia.pl+48662106226

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 23, 2026